{"id":45342,"date":"2025-10-30T23:07:23","date_gmt":"2025-10-30T15:07:23","guid":{"rendered":"https:\/\/flcube.com\/?p=45342"},"modified":"2025-10-30T23:07:25","modified_gmt":"2025-10-30T15:07:25","slug":"thermo-fisher-secures-8-875b-clario-acquisition-enhancing-digital%e2%80%91trial-endpoint-suite","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45342","title":{"rendered":"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite"},"content":{"rendered":"\n<p><strong>Thermo Fisher Scientific Inc. (<a href=\"https:\/\/www.google.com\/finance\/quote\/TMO:NYSE\">NYSE: TMO<\/a>)<\/strong> announced a definitive agreement to acquire <strong>Clario Holdings,\u202fInc.<\/strong>, a leader in endpoint\u2011data analytics for clinical trials. The purchase price of <strong>USD\u202f8.875\u202fbillion<\/strong> will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-why-clario-matters\">Why Clario Matters<\/h2>\n\n\n\n<p>Clario aggregates data from devices, sites, and patients, enabling pharmaceutical and biotech companies to <strong>digital\u2011ly collect, manage, and analyze clinical evidence<\/strong> across all phases of drug development. The platform has contributed to roughly <strong>70\u202f% of FDA drug approvals<\/strong> in the last decade, underscoring its influence on regulatory decision\u2011making.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-snapshot\">Financial Snapshot<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2025 Revenue<\/strong>: Clario is projected to generate <strong>\u2248 USD\u202f1.25\u202fbillion<\/strong> in gross revenues for the full year.<\/li>\n\n\n\n<li><strong>Deal Structure<\/strong>: Close\u2011cash payment of USD\u202f8.875\u202fbillion, supplemented by earn\u2011outs tied to post\u2011acquisition performance.<\/li>\n\n\n\n<li><strong>Synergies<\/strong>: Thermo\u202fFisher\u2019s existing diagnostics portfolio will dovetail with Clario\u2019s real\u2011time data analytics, creating a unified platform for clinical\u2011trial stakeholders.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-fit-for-thermo-fisher\">Strategic Fit for Thermo\u202fFisher<\/h2>\n\n\n\n<p>The acquisition cements Thermo\u202fFisher\u2019s reputation as a <strong>trusted partner<\/strong> for drug\u2011development partners. By fusing Clario\u2019s endpoint\u2011data engine with Thermo\u202fFisher\u2019s laboratory services, the company can offer <strong>faster, more confident trial decisions<\/strong> and streamlined data\u2011access for sponsors at every product\u2011development stage.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-customer-centric-benefits\">Customer\u2011Centric Benefits<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Speed\u2011to\u2011Decision<\/strong>: Sponsors can rapidly assess interim signals and adapt trial designs in real time.<\/li>\n\n\n\n<li><strong>Regulatory Confidence<\/strong>: Centralized, high\u2011quality endpoint data reduces variability and supports robust evidence packages for FDA submissions.<\/li>\n\n\n\n<li><strong>Digital\u2011First Ecosystem<\/strong>: End\u2011to\u2011end solutions\u2014from sample collection to data reporting\u2014are consolidated under one partner, lowering complexity for sponsors and study sites.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-industry-implications\">Industry Implications<\/h3>\n\n\n\n<p>The acquisition signals a broader trend toward <strong>data\u2011centric clinical\u2011trial infrastructure<\/strong>. As regulators increasingly favor digital evidence, Thermo\u202fFisher\u2019s expanded endpoint capabilities position it to capture a larger share of the <strong>$15\u202fbillion\u2011plus<\/strong> market for clinical\u2011trial data services.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45343,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[20,1261,523],"class_list":["post-45342","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-finance","tag-nyse-tmo","tag-thermo-fisher-scientific"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a leader in endpoint\u2011data analytics for clinical trials. The purchase price of USD\u202f8.875\u202fbillion will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45342\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite\" \/>\n<meta property=\"og:description\" content=\"Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a leader in endpoint\u2011data analytics for clinical trials. The purchase price of USD\u202f8.875\u202fbillion will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45342\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-30T15:07:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-30T15:07:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite\",\"datePublished\":\"2025-10-30T15:07:23+00:00\",\"dateModified\":\"2025-10-30T15:07:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342\"},\"wordCount\":330,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007-1.webp\",\"keywords\":[\"Finance\",\"NYSE: TMO\",\"Thermo Fisher Scientific\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45342#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45342\",\"name\":\"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007-1.webp\",\"datePublished\":\"2025-10-30T15:07:23+00:00\",\"dateModified\":\"2025-10-30T15:07:25+00:00\",\"description\":\"Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a leader in endpoint\u2011data analytics for clinical trials. The purchase price of USD\u202f8.875\u202fbillion will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45342\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Thermo\u202fFisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45342#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite - Insight, China&#039;s Pharmaceutical Industry","description":"Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a leader in endpoint\u2011data analytics for clinical trials. The purchase price of USD\u202f8.875\u202fbillion will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45342","og_locale":"en_US","og_type":"article","og_title":"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite","og_description":"Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a leader in endpoint\u2011data analytics for clinical trials. The purchase price of USD\u202f8.875\u202fbillion will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.","og_url":"https:\/\/flcube.com\/?p=45342","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-30T15:07:23+00:00","article_modified_time":"2025-10-30T15:07:25+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45342#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45342"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite","datePublished":"2025-10-30T15:07:23+00:00","dateModified":"2025-10-30T15:07:25+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45342"},"wordCount":330,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45342#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp","keywords":["Finance","NYSE: TMO","Thermo Fisher Scientific"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45342#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45342","url":"https:\/\/flcube.com\/?p=45342","name":"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45342#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45342#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp","datePublished":"2025-10-30T15:07:23+00:00","dateModified":"2025-10-30T15:07:25+00:00","description":"Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings,\u202fInc., a leader in endpoint\u2011data analytics for clinical trials. The purchase price of USD\u202f8.875\u202fbillion will be paid in cash at closing, with additional earn\u2011outs and milestone payments contingent on future performance.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45342#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45342"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45342#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp","width":1080,"height":608,"caption":"Thermo\u202fFisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45342#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Thermo Fisher Secures $8.875B Clario Acquisition, Enhancing Digital\u2011Trial Endpoint Suite"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45342"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45342\/revisions"}],"predecessor-version":[{"id":45344,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45342\/revisions\/45344"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45343"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}